Promising new treatment for teens with painful skin condition

NCT ID NCT07213973

Recruiting now Disease control Sponsor: Incyte Corporation Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times

Summary

This study tests a new drug called povorcitinib in 40 teenagers aged 12 to 17 with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and tunnels. The goal is to see if the drug is safe and can reduce symptoms over 54 weeks. Participants take the drug daily and are monitored for side effects and improvement in their skin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Advanced Medical Research Pc
RECRUITING

Sandy Springs, Georgia, 30328, United States
Bellaire Dermatology Associates Bda
RECRUITING

Bellaire, Texas, 77401, United States
Boeson Research Missoula 2825 Fort Missoula Rd
RECRUITING

Missoula, Montana, 59804, United States
Boston Childrens Hospital
NOT_YET_RECRUITING

Boston, Massachusetts, 02115, United States
Dermatology Skin Cancer Center Leawood
RECRUITING

Leawood, Kansas, 66211, United States
Dermcare Clinic
RECRUITING

Mississauga, Ontario, L4W 0C2, Canada
Endeavor Health Medical Group
RECRUITING

Skokie, Illinois, 60077, United States
Equity Medical
RECRUITING

Bowling Green, Kentucky, 42104, United States
Geisinger Medical Center
NOT_YET_RECRUITING

Danville, Pennsylvania, 17822, United States
Johns Hopkins Oncology Center
RECRUITING

Baltimore, Maryland, 21287, United States
Jordan Valley Dermatology Center
RECRUITING

South Jordan, Utah, 84095, United States
Medical Dermatology Specialists Phoenix
RECRUITING

Phoenix, Arizona, 85006, United States
Oakland Hills Dermatology Pc
RECRUITING

Auburn Hills, Michigan, 48326, United States
Revival Research Institute, Llc Troy
RECRUITING

Troy, Michigan, 48084, United States
Saguaro Dermatology
RECRUITING

Phoenix, Arizona, 85008, United States
Skin Research of South Florida, Llc
RECRUITING

Miami, Florida, 33173, United States
Skincare Studio Dermatology Centre
RECRUITING

St. John's, A1E 1V4, Canada
Texas Dermatology Research Center
RECRUITING

Dallas, Texas, 75246, United States
The Hospital For Sick Children
RECRUITING

Toronto, Ontario, M5G 1X8, Canada
Trueblue Clinical Research
RECRUITING

Tampa, Florida, 33609, United States
Uconn Health
NOT_YET_RECRUITING

Farmington, Connecticut, 06030, United States
University of Alabama At Birmingham
NOT_YET_RECRUITING

Birmingham, Alabama, 35233, United States
University of Miami Miller School of Medicine
RECRUITING

Miami, Florida, 33136, United States
University of New Mexico Hospital
RECRUITING

Albuquerque, New Mexico, 87102, United States
Washington University
RECRUITING

St Louis, Missouri, 63110, United States
Wayne State University Physician Group Dermatology
RECRUITING

Detroit, Michigan, 48201, United States
York Dermatology Center
RECRUITING

Richmond Hill, Ontario, L4B 1L1, Canada

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA (HS)